These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33636024)

  • 1. Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α.
    Ren H; Hu F; Wang D; Kang X; Feng X; Zhang L; Zhou B; Liu S; Yuan G
    Hepatology; 2021 Aug; 74(2):723-740. PubMed ID: 33636024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
    Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
    J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
    Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
    J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
    Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
    J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway.
    Leal H; Cardoso J; Valério P; Quatorze M; Carmona V; Cunha-Santos J; Pereira de Almeida L; Pereira C; Cavadas C; Gomes P
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD
    Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
    Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
    [No Abstract]   [Full Text] [Related]  

  • 7. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
    Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
    Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
    Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
    Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
    Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silybin Restored CYP3A Expression through the Sirtuin 2/Nuclear Factor κ-B Pathway in Mouse Nonalcoholic Fatty Liver Disease.
    Zhang R; Xu D; Zhang Y; Wang R; Yang N; Lou Y; Zhao H; Aa J; Wang G; Xie Y
    Drug Metab Dispos; 2021 Sep; 49(9):770-779. PubMed ID: 34183378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Sirtuin 2 in sustaining functional integrity of the liver.
    Park S; Chung MJ; Son JY; Yun HH; Park JM; Yim JH; Jung SJ; Lee SH; Jeong KS
    Life Sci; 2021 Nov; 285():119997. PubMed ID: 34597608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
    Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
    Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silybin inhibits NLRP3 inflammasome assembly through the NAD
    Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y
    FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites.
    Li X; Du Y; Xue C; Kang X; Sun C; Peng H; Fang L; Han Y; Xu X; Zhao C
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L; Liu Y; Zhao Y; Li M; Guo L
    Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
    Gao L; Wang PX; Zhang Y; Yu CJ; Ji Y; Wang X; Zhang P; Jiang X; Jin H; Huang Z; Zhang ZR; Li H
    J Hepatol; 2016 Jul; 65(1):125-136. PubMed ID: 27032381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
    Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
    Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease.
    Pan X; Zhang Y
    Chin Med J (Engl); 2022 May; 135(10):1172-1181. PubMed ID: 35191422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
    Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
    Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.